Navigation Links
PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era
Date:9/23/2009

g statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business, including, but not limited to, the successful business integration and anticipated synergy achievements in connection with the ClinPhone acquisition; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended June 30, 2009 as filed with the SEC on August 28, 2009, which "Risk Factors" discussion is incorporated by reference in this press release. The forward-looking statements included in this press release represent the Company's estimates as of the date of this release. The Company specifically dis
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
3. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
4. PAREXEL International to Present at the Wachovia Equity Conference
5. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
6. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
7. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
8. PAREXEL Receives BioSingapore Award for Best Performing CRO
9. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
10. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
11. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... BURNIE, Md. , Aug. 19, 2014 ... clinical research industry, recently announced the formation of the ... pleased to announce the addition of Dr. William ... Photo - http://photos.prnewswire.com/prnh/20140818/136957 The ... across a variety of therapeutic areas and set strategic ...
(Date:8/19/2014)... Sales Horizons, a leader in sales training, ... skills training course to help companies develop clinical ... spend the majority of their time on client sites ... physician practice – providing support and education to both ... Horizons believes clinical staff are and should be considered ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... , August 18, 2014 ... Transparency Market Research "Life Science Reagents Market(Products- PCR ... Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and Others; End ... Institutions, Clinical Laboratories, and Forensic Laboratories)- Global Industry ... - 2019", the global life science reagents market ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... Multiporator / Electroporator 2510 , , , , , , , ... Protocol No. 4308 915.523 03/2002 , , , ... , Microorganism , ... Cell type , Bacteria, gram positive, , ...
... , , , , , , Multiporator / Electroporator 2510 , , , ... , Transformation Protocol , Protocol No. 4308 915.520 ... , , , , , , ... , Cell type , ...
... Multiporator , , , , , , , , ... Protocol No. 4308 915.046 11/2001 , , , , ... , Cell line , L2, Schneider ... Transfection with , pActin-SV-EGFP, , ...
Cached Biology Technology:Mycobacterium avium 2Listeria monocytogenes 2L2 2
(Date:8/20/2014)... by researchers at the University of Missouri School of ... life-threatening heart condition caused by muscular dystrophy. , ... Ph.D., the leading author of the study and assistant ... of Molecular Microbiology and Immunology. "This is just a ... a treatment for people with this devastating heart condition, ...
(Date:8/20/2014)... light and its energy is finally utilized for ... devices, mostly build from silicon based semiconductors, also ... for the development of cheaper and renewable photovoltaics ... membrane protein complexes of photosynthesis. Prof. Dr. Matthias ... thermophilic cyanobacteria that live in a hot spring ...
(Date:8/19/2014)... increasing caesarean section rate, suggests a new commentary published ... of Obstetrics and Gynaecology (BJOG) . , China has ... world. Of 16 million babies born in 2010, approximately ... not known, the current Chinese language literature on caesarean ... 36% to 58%. However, before the 1980s, the caesarean ...
Breaking Biology News(10 mins):Gene therapy protects mice from lethal heart condition, MU researchers find 2A semi-artificial leaf faster than 'natural' photosynthesis 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3
... - The right combination of compounds produced by a ... pesticides and are safer for wildlife and grazing animals, ... fungus called an endophyte. It lives symbiotically, feeding off ... protection from insects such as black cutworm. But Neotyphodium ...
... metabolic state of glioma stem cells, which give rise ... the brain cancer cells to which they give birth, ... and cause recurrence later. Researchers with the UCLA ... Center also found for the first time that these ...
... The 141st annual meeting of the American Fisheries Society will ... of this year,s conference is "New Frontiers in Fisheries Management ... more information, visit http://afs2011.org/ All talks will ... are below: Eat but don,t get eaten: after restoration, ...
Cached Biology News:Scientists make turfgrass safer for animals, deadly for insects 2Metabolic state of brain cancer stem cells significantly different than the cancer cells they create 2USGS research frontiers on fish at the American Fisheries Society Conference 2USGS research frontiers on fish at the American Fisheries Society Conference 3USGS research frontiers on fish at the American Fisheries Society Conference 4USGS research frontiers on fish at the American Fisheries Society Conference 5USGS research frontiers on fish at the American Fisheries Society Conference 6USGS research frontiers on fish at the American Fisheries Society Conference 7
...
... The Helios gene gun optimization kit ... in optimizing parameters affecting particle delivery with ... 0.25 g each of 0.6 micrometer, 1.0 ... included is a cartridge kit, that provides ...
... Cellerity is Tecans fully automated solution ... cost-effective, fast automation for cell-line maintenance, ... a modular system built upon standard, ... modified liquid handling configuration capable of ...
... Expression (SAGE) is a powerful genome-wide ... cost-effective outsourcing solution for sequencing of ... SAGE sequencing service provides our clients ... Phred20 read lengths (40 SAGE tags ...
Biology Products: